New treatment for erectile dysfunction with enlarged prostate
Part of Kidney & urinary, Mental health clinical trials.
This trial tests a new drug, DTT106, for men who have both erectile dysfunction and an enlarged prostate (BPH). It is for men already taking dutasteride and tamsulosin and aims to see if the new treatment improves erections better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man aged 40 or older.
- You are sexually active and have tried to have sex at least once a week over the past month with a regular partner.
- You are currently taking dutasteride and tamsulosin together and have been on them for a while.
- You have been diagnosed with erectile dysfunction (trouble getting or keeping an erection).
- You have not had any major prostate surgery, radiation, or other invasive treatments for an enlarged prostate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine (DNN.65.21.005) to see if it helps men with an enlarged prostate who have trouble urinating. It may be an option if you are 50 or older and have symptoms like needing to go often or having a weak stream.
This trial studies whether daily tadalafil (5 mg) can improve early urinary trouble and erection function after endoscopic prostate tissue removal. It may help men whose urinary symptoms continued even after prior medicine.
This Phase 2 study tests how safe and effective a topical medicine (BZ371A) is for men after prostate surgery, with the goal of improving sexual recovery and monitoring side effects. You may be able to join if you meet specific timing, health, and medication criteria after radical prostatectomy.
This Phase 3 study tests how well a Toronto Association treatment works for men who have both erectile dysfunction and premature ejaculation, while also checking safety. You may be able to join if your symptoms match the study targets and you can stay on a steady, stable sexual routine and relationship during the study.
This trial tests a new, once-daily tablet (H077) compared to the standard medicine silodosin for treating symptoms of an enlarged prostate. It aims to see if the new medicine works as well and is safe.
This trial tests new treatment strategies for benign prostatic hyperplasia (BPH, an enlarged prostate) using a special MRI scan and a medication called finasteride. It aims to find better ways to manage symptoms and identify markers that predict response.
Hear when a new Erectile Dysfunction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.